Induced Pluripotent Stem Cells Market Soars at 12.23% CAGR Between 2019 and 2025

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Los Angeles, United States - September 12, 2019 /MarketersMedia/ —

In a recent research report published by QY Research, titled, “Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2019-2025” has analyzed the global induced pluripotent stem cells market. The report is a depth research paper about the various areas of the market, namely, market size, drivers and restrains, segment analysis, regional analysis, key players, and competitive landscape.

In 2018, the global induced pluripotent stem cells market size was valued at US$71.7 mn and it is expected to reach US$160.9 mn by the end of 2025, rising at a CAGR of 12.23% during 2019-2025.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1243625/global-induced-pluripotent-stem-cells-market

Global Induced Pluripotent Stem Cells Market: Drivers and Restraints

The global induced pluripotent stem cells market is expected to grow with its increasing usage as a regenerative medicine for damaged tissues and diseased organs. This is attributed towards an interesting property of pluripotent stem cells to form various types of adult cells such as neurons, liver, heart, and pancreatic cells. They also can make any cell or tissue combat diseases such as spinal cord injury, diabetes, heart disease, and leukaemia. These cells can be modified to match patient’s genetic makeup. Governments and private sectors are investing heavily in the development of pluripotent stem cells as they enable initial human growth. Its ability to produce customized cells, rejection-proof cells, and tissues for efficacious transplantation is expected to offer lucrative opportunities to the global market for induced pluripotent stem cells.

Increasing interest among scientists to understand and develop stem cells for various ailments is expected to contribute towards the growth of stem cells. Its various roles in clinical applications, research and awareness among people about the benefits of stem cells will boost the market growth during the forecast period.

However, the treatment and reprogramming of cells is a lengthy and costly process. Also the market has certain ethical risks associated with it. Other factors like low efficiency, proliferation rates, potential tumour risk, and incomplete programming can hamper the growth of the global induced pluripotent stem cells market.

Global Induced Pluripotent Stem Cells Market: Segment Analysis

The global induced pluripotent stem cells market is segmented on the basis of type and application. The type segment includes human iPSCs and mouse iPSCs. The application segment includes academic research, drug development and discovery, toxicity screening, regenerative medicine, and others.

Global Induced Pluripotent Stem Cells Market: Regional Analysis

The report analysis various region of the global induced pluripotent stem cells market such as United States, Europe, Asia Pacific (China, India, and Japan), Southeast Asia, Central & South America, and other regions. The market is expected to grow in regions like Asia due to increasing number of research projects. Currently, North America dominates the global market, followed by Europe.

Global Induced Pluripotent Stem Cells Market: Key Players

The key players covered in the report are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc., Fate Therapeutics, Inc., Pluricell Biotech, Cell Inspire Biotechnology, and ReproCELL.

Global Induced Pluripotent Stem Cells Market: Competitive Landscape

Fujifilm Holding Corporation (CDI) is a leading company. They recently announced a collaboration with Axcelead Drug Discovery Partners, Inc. to provide integrated platform for drug discovery solutions. Both the companies will together work towards developing new drug efficacy evaluation methods. They will also develop toxicity testing to meet specific client needs. They will also work towards R&D of iPSC to study ability to differentiate into diverse cells and its infinite reproduction capabilities. As the demand for iPSC is expected to grow further they are planning a standardizing safety tests using differentiated cells.

The increasing competition amongst manufactures is fuelling the need for developmental strategies such as product development, innovative technologies, and joint ventures to boost share in the market. This strategy of Fujifilm Holding Corporation (CDI) is expected to push the company towards significant development in the medical field and set high benchmark for other manufacturers.

Get Complete Report in your Inbox within 24 hours at 3,900 USD https://www.qyresearch.com/settlement/pre/eb11190375650824d3d7695db8b374ce,0,1,Global-Induced-Pluripotent-Stem-Cells-Market-Size-Status-and-Forecast

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.

Contact Info:
Name: Rahul Singh
Email: Send Email
Organization: QY Research, Inc
Address: QY Research, INC. 17890 Castleton, Suite 218, Los Angeles, CA - 91748
Phone: 6264288800
Website: https://www.qyresearch.com/index/detail/1243625/global-induced-pluripotent-stem-cells-market

Source URL: https://marketersmedia.com/induced-pluripotent-stem-cells-market-soars-at-1223-cagr-between-2019-and-2025/88918267

Source: MarketersMedia

Release ID: 88918267

Other Press Releases

Egypt's el-Sissi dismisses corruption allegations

Sep 15, 2019

CAIRO — Egypt's president on Saturday dismissed corruption allegations made by a businessman-in- exile about the country's military as "sheer lies and defamation." In viral social media videos posted over the past week, the entrepreneur alleged large-scale misuse of public funds in the building of luxurious hotels, presidential palaces and a tomb for President Abdel-Fattah el-Sissi's mother who died in 2014. "I've built presidential palaces and I will continue to do so," el-Sissi, a general-turned-president, said in televised comments. "I am building a new country. ... All of this is not mine. It's Egypt's." El-Sissi was responding to claims by...

US stocks are mixed as health care gains, tech drops

Sep 15, 2019

NEW YORK — U.S. stocks gave a mixed performance in early trading on Friday as health care, banks and industrial companies gained ground and offset a decline in technology stocks. Still, stocks are on track for their third straight weekly gain, having been bolstered in prior sessions by an easing of tensions in the U.S.-China trade war. Bond yields rose sharply after the government reported that Americans kept spending money in August, particularly on cars. The yield on the 10-year Treasury rose to 1.83% from 1.79% late Thursday. That helped lift bank stocks, which rely on higher yields to set...

EU competition chief hints at new data rules for tech firms

Sep 15, 2019

LONDON — The European Union's powerful competition chief indicated Friday that she's looking at expanding regulations on personal data, dropping an initial hint about how she plans to use new powers against tech companies. Margrethe Vestager said that while Europeans have control over their own data through the EU's world-leading data privacy rules, they don't address problems stemming from the way companies use other people's data, "to draw conclusions about me or to undermine democracy." "So we may also need broader rules to make sure that the way companies collect and use data doesn't harm the fundamental values of our...

Pesticide criticized in bee deaths could also kill birds

Sep 15, 2019

PORTLAND, Maine — Scientists studying a widely used pesticide say even small doses of the chemical can have crippling health effects on migrating birds, and it might be contributing to declines in their overall populations. The researchers with the University of Saskatchewan will publish their research about the insect-killer imidacloprid in the journal Science on Friday. The insecticide is among a class called neonicotinoids that has been widely studied for its health impacts on bees. The scientists studied white-crowned sparrows that consumed small doses of the pesticide and found that the birds experienced weight loss and delays in migration. They...

Facebook expands new tool aiming to shrink 'news deserts'

Sep 15, 2019

SAN FRANCISCO — Facebook is trying to coax "news deserts" into bloom with the second major expansion of a tool that exposes people to more local news and information. But the social network confesses that it still has a lot to learn. The social media giant said Thursday it is expanding its "Today In" service to 6,000 cities and towns across the U.S., up from 400 in its previous iteration . Launched in early 2018, the service lets Facebook users opt into local news and information from local organizations. Such news can include missing-person alerts, local election results, road closures...

About Us

Stillsurge is a home for individuals to find the latest day-to-day Science and Technology news which electrify and empower their knowledge.